Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPA: Prophylactic HDM-SLIT for Asthma Prevention
NCT05113394Phase 2Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Feb 2027
- Primary completion
- Feb 2028
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Odactra with Placebo (2 arms). Primary endpoint: Number of Participants with Asthma. Planned start Feb 2027; status: withdrawn.
02
Drugs
SQ SLIT-tablet
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05113394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05113394.